RLBP1 Human

Retinaldehyde Binding Protein 1 Human Recombinant
Cat. No.
BT12429
Source
Escherichia Coli.
Synonyms
Retinaldehyde Binding Protein 1, Cellular Retinaldehyde-Binding Protein, CRALBP.
Appearance
Sterile Filtered clear solution.
Purity
Greater than 90% as determined by SDS-PAGE.
Usage
THE BioTeks products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

RLBP1 Human Recombinant produced in E.coli is a single, non-glycosylated polypeptide chain containing 340 amino acids (1-317) and having a molecular mass of 38.9 kDa. RLBP1 is fused to a 23 amino acid His-tag at N-terminus.

Product Specs

Introduction
RLBP1, a 36-kD water-soluble protein, functions in the visual cycle by transporting 11-cis-retinal or 11-cis-retinaldehyde. Mutations in the RLBP1 gene are associated with retinal diseases like retinitis punctata albescens, severe rod-cone dystrophy, and Bothnia dystrophy, a non-syndromic autosomal recessive form of retinitis pigmentosa.
Description
Recombinant human RLBP1, expressed in E. coli, is a non-glycosylated polypeptide chain with a His-tag at the N-terminus. It consists of 340 amino acids (residues 1-317) and has a molecular weight of 38.9 kDa.
Physical Appearance
A clear solution that has been sterilized by filtration.
Formulation
The RLBP1 solution has a concentration of 1mg/ml and is formulated in 20mM Tris-HCl buffer with a pH of 8.0, 0.4M Urea, and 10% glycerol.
Stability
For short-term storage (2-4 weeks), keep at 4°C. For extended storage, freeze at -20°C. Adding a carrier protein (0.1% HSA or BSA) is recommended for long-term storage. Avoid repeated freezing and thawing.
Purity
Purity exceeds 90%, as determined by SDS-PAGE analysis.
Synonyms
Retinaldehyde Binding Protein 1, Cellular Retinaldehyde-Binding Protein, CRALBP.
Source
Escherichia Coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MGSMSEGVGT FRMVPEEEQE LRAQLEQLTT KDHGPVFGPC SQLPRHTLQK AKDELNEREE TREEAVRELQ EMVQAQAASG EELAVAVAER VQEKDSGFFL RFIRARKFNV GRAYELLRGY VNFRLQYPEL FDSLSPEAVR CTIEAGYPGV LSSRDKYGRV VMLFNIENWQ SQEITFDEIL QAYCFILEKL LENEETQING FCIIENFKGF TMQQAASLRT SDLRKMVDML QDSFPARFKA IHFIHQPWYF TTTYNVVKPF LKSKLLERVF VHGDDLSGFY QEIDENILPS DFGGTLPKYD GKAVAEQLFG PQAQAENTAF

Product Science Overview

Discovery and Structure

The cellular retinol-binding protein (CRBP) was first discovered in 1973 from lung tissues by Bashor et al. There are three categories of cellular retinol-binding proteins: cellular retinol-binding protein, cellular retinoic acid-binding protein, and cellular retinaldehyde-binding protein (CRALBP) . CRALBP was first discovered in 1977 after it was purified from retina and retinal pigment epithelial cells .

The RLBP1 gene is located on human chromosome 15, specifically on 15q26.1 . The gene is composed of 8 exons and 7 introns . The protein itself contains 360 amino acid residues .

Function

RLBP1 is primarily involved in the visual cycle, where it acts as an 11-cis-retinal acceptor. This protein facilitates the enzymatic isomerization of all 11-trans-retinal to 11-cis-retinal, which is crucial for the function of rod and cone cells in the retina . The protein carries 11-cis-retinaldehyde or 11-cis-retinal as its physiological ligands .

Tissue Distribution

While RLBP1 is predominantly found in the retina and retinal pigment epithelial cells, it is also expressed in other cell types. It is majorly found in the iris, cornea, ciliary epithelium, Muller cells, the pineal gland, and oligodendrocytes of the optic nerve and brain . The function of RLBP1 in cells not related to the eyes is not yet fully understood .

Clinical Significance

Mutations in the RLBP1 gene have been associated with several retinal dystrophies, including Bothnia retinal dystrophy, fundus albipunctatus, and Newfoundland rod-cone dystrophy . These conditions are characterized by progressive vision loss and other visual impairments. Studies have shown that recombinant CRALBP containing certain mutations, such as the R150Q substitution, lacks the ability to bind 11-cis-retinaldehyde, leading to disruptions in retinal vitamin A metabolism .

Recombinant RLBP1

Human recombinant RLBP1 is produced using recombinant DNA technology, which involves inserting the human RLBP1 gene into a suitable expression system, such as bacteria or yeast. This allows for the production of large quantities of the protein for research and therapeutic purposes. Recombinant RLBP1 is used in various studies to understand its function, structure, and role in retinal diseases.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.